344 reports of this reaction
2.2% of all TESTOSTERONE CYPIONATE reports
#10 most reported adverse reaction
THROMBOSIS is the #10 most commonly reported adverse reaction for TESTOSTERONE CYPIONATE, manufactured by Pharmacia & Upjohn Company LLC. There are 344 FDA adverse event reports linking TESTOSTERONE CYPIONATE to THROMBOSIS. This represents approximately 2.2% of all 15,890 adverse event reports for this drug.
Patients taking TESTOSTERONE CYPIONATE who experience thrombosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
THROMBOSIS is a less commonly reported adverse event for TESTOSTERONE CYPIONATE, but still significant enough to appear in the safety profile.
In addition to thrombosis, the following adverse reactions have been reported for TESTOSTERONE CYPIONATE:
The following drugs have also been linked to thrombosis in FDA adverse event reports:
THROMBOSIS has been reported as an adverse event in 344 FDA reports for TESTOSTERONE CYPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
THROMBOSIS accounts for approximately 2.2% of all adverse event reports for TESTOSTERONE CYPIONATE, making it a notable side effect.
If you experience thrombosis while taking TESTOSTERONE CYPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.